TP53 and myeloid neoplasm: As with other myeloid neoplasms, heterozygous TP53-mutated clones may rarely be found early in the disease process of MPNs, whereas the loss of the wild-type allele is associated with a 15-fold higher risk of leukemic progression [37,38].